Chemokines in gastrointestinal disorders.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Current Drug Targets

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/138945006775270222PMID 16454699
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease

  2005cited by this paper
• CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.

  2005cited by this paper
• Gut-level decisions in peace and war

  2005cited by this paper
• GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors.

  2005cited by this paper
• Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis.

  2005cited by this paper
• CXCL16 is a novel angiogenic factor for human umbilical vein endothelial cells.

  2005cited by this paper
• Regulatory T cells and intestinal homeostasis

  2005cited by this paper
• Increased Expression of CCL20 in Human Inflammatory Bowel Disease

  2004cited by this paper
• Toll-like receptor signalling

  2004cited by this paper
• Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo

  2004cited by this paper
• Vectors based on autonomous parvoviruses: novel tools to treat cancer?

  2004cited by this paper
• Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors.

  2004cited by this paper
• CCL16 activates an angiogenic program in vascular endothelial cells.

  2004cited by this paper
• BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells

  2004cited by this paper
• NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses

  2004cited by this paper
• Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host's immune system: implications for chemokine-based cancer immunotherapy.

  2004cited by this paper
• Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.

  2004cited by this paper
• Human eosinophils produce the T cell‐attracting chemokines MIG and IP‐10 upon stimulation with IFN‐γ

  2004cited by this paper
• War and peace at mucosal surfaces

  2004cited by this paper
• Platelets Release CXCL4L1, a Nonallelic Variant of the Chemokine Platelet Factor-4/CXCL4 and Potent Inhibitor of Angiogenesis

  2004cited by this paper
• CXC chemokines in angiogenesis of cancer.

  2004cited by this paper
• Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.

  2004cited by this paper
• The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines.

  2004cited by this paper
• Optimizing anti-TNF treatment in inflammatory bowel disease.

  2004cited by this paper
• Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells.

  2004cited by this paper
• Cancer and the chemokine network

  2004cited by this paper
• Chemokine-protease interactions in cancer.

  2004cited by this paper
• Chemokines: multiple levels of leukocyte migration control.

  2004cited by this paper
• Primate defensins

  2004cited by this paper
• The role of Paneth cells and their antimicrobial peptides in innate host defense.

  2004cited by this paper
• CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn's disease and selective GCP‐2/CXCL6 expression in inflamed intestinal tissue

  2004cited by this paper
• Analysis of the role of chemokines in angiogenesis.

  2003cited by this paper
• Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity.

  2003cited by this paper
• Intestinal IgA synthesis: regulation of front-line body defences

  2003cited by this paper
• Defensins: antimicrobial peptides of innate immunity

  2003cited by this paper
• Regulation of the Chemokine Receptor CXCR4 by Hypoxia

  2003cited by this paper
• The immune response of Drosophila

  2003cited by this paper
• The mucosal immune system

  2003cited by this paper
• TOLL-like receptors linking innate and adaptive immune response.

  2003cited by this paper
• Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease

  2003cited by this paper
• Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing.

  2003cited by this paper
• Recognition of pathogen-associated molecular patterns by TLR family.

  2003cited by this paper
• Anatomical basis of tolerance and immunity to intestinal antigens

  2003cited by this paper
• The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.

  2003cited by this paper
• Role of Chemokines in Angiogenesis: CXCL12/SDF‐1 and CXCR4 Interaction, a Key Regulator of Endothelial Cell Responses

  2003cited by this paper
• Microbial Toll‐like receptor ligands differentially regulate CXCL10/IP‐10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN‐γ and provide a mechanism for enhanced synovial chemokine levels in septic arthritis

  2003cited by this paper
• Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities.

  2003cited by this paper
• Chemokines in Lymphocyte Trafficking and Intestinal Immunity

  2003cited by this paper
• PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.

  2003cited by this paper
• The CC chemokine CCL20 and its receptor CCR6.

  2003cited by this paper
• Immunobiology of epithelial chemokines in the intestinal mucosa.

  2003cited by this paper
• Role of chemokines and chemokine receptors in the gastrointestinal tract

  2002cited by this paper
• Equimolar doses of balsalazide and mesalamine: are we comparing apples and oranges?

  2002cited by this paper
• Transfection of colorectal cancer cells with chemokine MCP-3 (monocyte chemotactic protein-3) gene retards tumor growth and inhibits tumor metastasis.

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• International Union of Pharmacology. XXX. Update on Chemokine Receptor Nomenclature

  2002cited by this paper
• Ulcerative colitis

  2002cited by this paper
• Colonic epithelial cells are a major site of macrophage inflammatory protein 3α (MIP-3α) production in normal colon and inflammatory bowel disease

  2002cited by this paper
• Chemokines: agents for the immunotherapy of cancer?

  2002cited by this paper
• Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma*

  2002cited by this paper
• Elevated serum eotaxin levels in patients with inflammatory bowel disease

  2002cited by this paper
• Intestinal attraction: CCL25 functions in effector lymphocyte recruitment to the small intestine.

  2002cited by this paper
• B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue

  2002cited by this paper
• Chemokines and the tissue-specific migration of lymphocytes.

  2002cited by this paper
• The role of chemokines in linking innate and adaptive immunity.

  2002cited by this paper
• The increased expression of an array of C-X-C and C-C chemokines in the colonic mucosa of patients with ulcerative colitis: regulation by corticosteroids

  2002cited by this paper
• Hypoxia — a key regulatory factor in tumour growth

  2002cited by this paper
• Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease

  2002cited by this paper
• Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival

  2002cited by this paper
• Crohn's disease

  2002cited by this paper
• Collaboration of epithelial cells with organized mucosal lymphoid tissues

  2001cited by this paper
• Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique

  2001cited by this paper
• Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

  2001cited by this paper
• Molecular mechanisms of blood vessel growth.

  2001cited by this paper
• Chemokines: immunology's high impact factors

  2001cited by this paper
• MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma.

  2001cited by this paper
• A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

  2001cited by this paper
• An overview of the immune system.

  2001cited by this paper
• Transduction of human MCP‐3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts

  2001cited by this paper
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• Intraepithelial lymphocytes: exploring the Third Way in immunology

  2001cited by this paper
• Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1beta mediated by a tumor-specific vector, HVJ cationic liposomes.

  2001cited by this paper
• Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn's disease.

  2001cited by this paper
• Chemokines in pathology and medicine

  2001cited by this paper
• Different Subsets of Enteric Bacteria Induce and Perpetuate Experimental Colitis in Rats and Mice

  2001cited by this paper
• The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo.

  2001cited by this paper
• Chemokines in immunity.

  2001cited by this paper
• Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.

  2001cited by this paper
• Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle.

  2001cited by this paper
• Dancing to the tune of chemokines

  2001cited by this paper
• Increased Serum Levels of Eotaxin in Patients with Inflammatory Bowel Disease

  2001cited by this paper
• Tissue cytokine and chemokine expression in inflammatory bowel disease

  2001cited by this paper
• Man the barrier! strategic defences in the intestinal mucosa

  2001cited by this paper
• Lymphocyte traffic control by chemokines

  2001cited by this paper
• Periscope, up! Monitoring microbes in the intestine

  2001cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• International union of pharmacology. XXII. Nomenclature for chemokine receptors.

  2000cited by this paper
• Enhanced production of IL‐8 in chronic but not in early ileal lesions of Crohn's disease (CD)

  2000cited by this paper
• Intratumoral Coinjection of Two Adenoviruses, One Encoding the Chemokine IFN-γ-Inducible Protein-10 and Another Encoding IL-12, Results in Marked Antitumoral Synergy1

  2000cited by this paper
• Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa.

  2000cited by this paper

• Biomarkers and immunomodulatory effect of erythropoietin in postoperative ileus

  2026cites this paper
• Centipeda minima Extract Attenuates Dextran Sodium Sulfate-Induced Acute Colitis in Mice by Inhibiting Macrophage Activation and Monocyte Chemotaxis

  2021cites this paper
• Mechano-Regulation of Gene Expression in the Gut: Implications in Pathophysiology and Therapeutic Approaches in Obstructive, Inflammatory, and Functional Bowel Disorders

  2021cites this paper
• Dysregulated mucosal immune responses in microscopic colitis patients

  2016cites this paper
• Chapter 40 - Lymphocyte Trafficking to Mucosal Tissues

  2015cites this paper
• Enhanced Levels of Chemokines and Their Receptors in the Colon of Microscopic Colitis Patients Indicate Mixed Immune Cell Recruitment

  2015cites this paper
• Metabolic Inflammation in Inflammatory Bowel Disease: Crosstalk Between Adipose Tissue and Bowel

  2015cites this paper
• Mechanical Stress Is a Pro-Inflammatory Stimulus in the Gut: In Vitro, In Vivo and Ex Vivo Evidence

  2014cites this paper
• Anti-colorectal cancer immunity : control ‘the force’!

  2013cites this paper
• Inflammatory Disorders of the Small Intestine

  2012cites this paper
• Chemokine C‐C motif receptor 5 and C‐C motif ligand 5 promote cancer cell migration under hypoxia

  2012cites this paper
• Targeting T‐cell migration in inflammatory bowel disease

  2012cites this paper
• Temporal Colonic Gene Expression Profiling in the Recurrent Colitis Model Identifies Early and Chronic Inflammatory Processes

  2012cites this paper
• SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation

  2011cites this paper
• Citrullination of CXCL12 Differentially Reduces CXCR4 and CXCR7 Binding with Loss of Inflammatory and Anti-HIV-1 Activity via CXCR41

  2009cites this paper
• The role of chemokines in intestinal inflammation and cancer.

  2009cites this paper
• The Atypical Chemokine Receptor D6 Contributes to the Development of Experimental Colitis 1

  2009influential citation
• Disrupted Expression of CXCL5 in Colorectal Cancer Is Associated with Rapid Tumor Formation in Rats and Poor Prognosis in Patients

  2008cites this paper
• Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours.

  2008cites this paper
• Blockade of CXCL12/CXCR4 Axis Ameliorates Murine Experimental Colitis

  2008influential citation
• N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study.

  2008cites this paper
• Intestinal Epithelial Cell Up-Regulation of LY6 Molecules during Colitis Results in Enhanced Chemokine Secretion

  2008cites this paper
• Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease.

  2008cites this paper
• Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte—epithelial cell interaction

  2008cites this paper
• Enhanced Chemokine Secretion LY 6 Molecules during Colitis Results in Intestinal Epithelial Cell Up-Regulation of

  2008cites this paper
• Influence of lactic acid bacteria and their spent culture supernatant on hydrogen peroxide-induced interleukin-8 synthesis and necrosis of Caco-2 cells

  2007cites this paper
• Targeting of Th1-associated chemokine receptors CXCR3 and CCR5 as therapeutic strategy for inflammatory diseases.

  2007cites this paper